EFG
LH icon

Ethos Financial Group’s Labcorp LH Stock Holding History

Ethos Financial Group’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$256K Sell
834
-204
-20% -$53.6K 0.02% 507
2026
Q1 		$277K Buy
+1,038
New +$281K 0.02% 420
2025
Q4 		– Sell
-993
Closed -$285K – 558
2025
Q3 		$285K Hold
993
– – 0.02% 371
2025
Q2 		$261K Buy
+993
New +$242K 0.02% 369

Other funds holding LH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ethos Financial Group's LH Position: Q2 2026 in Review

Ethos Financial Group reduced its Labcorp (LH) stake by 20% in Q2 2026, selling an estimated $53.6K and leaving 834 shares worth $256K. The position accounts for 0.02% of the portfolio, ranked #507.

Ethos Financial Group first reported a position in LH in Q2 2025 and has held it in 4 quarters since. The position peaked at $285K in Q3 2025. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Ethos Financial Group held 834 shares of Labcorp worth $256K as of Q2 2026.
  • Ethos Financial Group sold 204 Labcorp shares in Q2 2026, an estimated $53.6K.
  • Labcorp made up 0.02% of Ethos Financial Group's portfolio in Q2 2026, its #507 holding.
  • Ethos Financial Group first reported a position in Labcorp in Q2 2025 and has held it in 4 quarters since.
  • Ethos Financial Group's Labcorp position peaked at $285K in Q3 2025.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Ethos Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.